Related references
Note: Only part of the references are listed.Update on the diagnosis and management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS
Shruti Chaturvedi et al.
BLOOD (2020)
An update on the management of antiphospholipid syndrome
Mia Rodziewicz et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2020)
Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology
Jacob George et al.
KIDNEY360 (2020)
Antiphospholipid syndrome's genetic and epigenetic aspects
Annamaria Iuliano et al.
AUTOIMMUNITY REVIEWS (2019)
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
Gisa Ellrichmann et al.
JOURNAL OF NEUROLOGY (2019)
Is there a role for immunosuppression in antiphospholipid syndrome?
Ecem Sevim et al.
Hematology-American Society of Hematology Education Program (2019)
Genetic risk factors in thrombotic primary antiphospholipid syndrome: A systematic review with bioinformatic analyses
Md. Asiful Islam et al.
AUTOIMMUNITY REVIEWS (2018)
The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review
Ricard Cervera et al.
JOURNAL OF AUTOIMMUNITY (2018)
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
K. Legault et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement
Aleksandra Rymarz et al.
BMC NEPHROLOGY (2018)
B Cell Modulation Strategies in Autoimmune Diseases: new Concepts
Philippe Musette et al.
FRONTIERS IN IMMUNOLOGY (2018)
New oral anticoagulants and their reversal agents
Crista L. Laslo et al.
JOURNAL OF MIND AND MEDICAL SCIENCES (2018)
The MHC locus and genetic susceptibility to autoimmune and infectious diseases
Vasiliki Matzaraki et al.
GENOME BIOLOGY (2017)
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry
Ignasi Rodriguez-Pinto et al.
AUTOIMMUNITY REVIEWS (2016)
Catastrophic antiphospholipid syndrome: The current management approach
Ignasi Rodriguez-Pinto et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2016)
Treatment of catastrophic antiphospholipid syndrome
Nayef M. Kazzaz et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
Doruk Erkan et al.
TURKISH JOURNAL OF HEMATOLOGY (2016)
Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study
A. -P. Trouvin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Eculizumab Prevents Recurrent Antiphospholipid Antibody Syndrome and Enables Successful Renal Transplantation
B. E. Lonze et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Identification and treatment of APS renal involvement
M. G. Tektonidou
LUPUS (2014)
Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report
Andreas Kronbichler et al.
MEDICINE (2014)
Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes
G. Canaud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
A Pilot Open-Label Phase II Trial of Rituximab for Non-Criteria Manifestations of Antiphospholipid Syndrome
Doruk Erkan et al.
ARTHRITIS AND RHEUMATISM (2013)
Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab
Horacio Berman et al.
AUTOIMMUNITY REVIEWS (2013)
Brief Report: Induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab
Iuliana Shapira et al.
ARTHRITIS AND RHEUMATISM (2012)
Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome
Smita Vaidya
CLINICAL TRANSPLANTATION (2012)
Severe Vascular Lesions and Poor Functional Outcome in Kidney Transplant Recipients with Lupus Anticoagulant Antibodies
G. Canaud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Thrombotic microangiopathy: new insights
Kerstin Benz et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'
R. Cervera
LUPUS (2010)
B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses
Hugo Mouquet et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response
G. Cambridge et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies
Boonyarit Cheunsuchon et al.
NEPHROLOGY (2007)
Mortality in the catastrophic antiphospholipid syndrome - Causes of death and prognostic factors in a series of 250 patients
Silvia Bucciarelli et al.
ARTHRITIS AND RHEUMATISM (2006)
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia
SS Pierangeli et al.
ARTHRITIS AND RHEUMATISM (2005)
Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significance
A Taher et al.
LUPUS (2003)
Catastrophic antiphospholipid syndrome -: Clues to the pathogenesis from a series of 80 patients
RA Asherson et al.
MEDICINE (2001)
HLA class II alleles associations of anticardiolipin and anti-beta(2)GPI antibodies in a large series of European patients with systemic lupus erythematosus
M Galeazzi et al.
LUPUS (2000)
Share Paper
